Lamictal 100 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB24FNY13
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,604
Award facts
- Contract value 100% obligated
- $5,603.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,603.75 firm fixed-price delivery order is for the supply of LAMICTAL 100 MG TABLET 100S, a pharmaceutical product. The award has an ultimate completion date of January 11, 2024.
Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, with a significant focus on the DLA and military healthcare systems.
Quick answers
Who was awarded contract SPE2DB24FNY13?
SPE2DB24FNY13 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 10, 2024.
How much is contract SPE2DB24FNY13 worth?
The government has obligated $5,604 on SPE2DB24FNY13.
Is contract SPE2DB24FNY13 an order under another contract?
Yes. SPE2DB24FNY13 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB24FNY13 competed?
The extent of competition for SPE2DB24FNY13 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award